For years, many clinical and public health laboratories have relied on incumbent extraction workflows such as MagMAX™ Viral/Pathogen Ultra Nucleic Acid Isolation Kit as part of routine molecular diagnostic research operations. These systems became deeply integrated into high-volume testing environments during periods of rapid testing expansion, particularly across infectious disease and respiratory workflows.

Today, however, the operational environment inside molecular laboratories has changed significantly.

Testing volumes remain high, but laboratories are now operating under increasing financial pressure. Reagent costs continue to rise while reimbursement environments become more restrictive. At the same time, laboratories must continue delivering rapid turnaround times, maintain analytical sensitivity, and support increasingly diverse pathogen testing demands across bacterial, fungal, and viral workflows.

For many laboratories, extraction reagents have quietly become one of the largest recurring operational expenses within molecular testing workflows.

As a result, more laboratories are beginning to ask an important question:

Can extraction workflow costs be reduced without sacrificing analytical performance?

That question is driving growing interest in alternatives to incumbent extraction systems such as MagMAX™ Viral/Pathogen Ultra Nucleic Acid Isolation Kit.

Laboratories evaluating alternative workflows are no longer focused solely on reagent pricing. They are also considering:

  • Workflow simplification
  • Automation compatibility
  • Multi-pathogen flexibility
  • Operational scalability
  • Validation burden
  • Inventory management

HighPrep Viral-Pathogen DNA & RNA Kit was developed specifically to address these evolving operational realities.

Designed as an automation-ready alternative compatible with KingFisher™ Flex systems, HighPrep Viral-Pathogen DNA & RNA Kit supports bacterial DNA, fungal DNA, and viral RNA workflows using a single streamlined extraction protocol.

The goal is not simply to lower costs.

The goal is to help laboratories maintain analytical confidence while improving long-term workflow sustainability.

This shift reflects a broader trend occurring across molecular diagnostic research:

Laboratories are increasingly evaluating extraction workflows not only from a scientific perspective, but from an operational and financial one as well.




Quick Links: